Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/152301
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents

AutorSalado, Irene G. CSIC; Zaldívar-Díez, Josefa CSIC ORCID; Sebastián, Víctor CSIC ORCID; Li, Lingling CSIC; Geiger, Larissa; González Menéndez, Silvia CSIC ORCID; Campillo, Nuria E. CSIC ORCID ; Gil, Carmen CSIC ORCID ; Morales, Aixa V. CSIC ORCID; Pérez, Daniel I. CSIC ORCID; Martínez Gil, Ana CSIC ORCID
Palabras claveLRRK2 inhibitors
Protein kinase inhibitors
Indolinone
Adult neurogenesis
Neural stem cells
Regenerative medicine
Fecha de publicación29-sep-2017
EditorElsevier
CitaciónEuropean Journal of Medicinal Chemistry 138: 328–342 (2017)
ResumenLeucine-rich repeat kinase 2 (LRRK2) is one of the most pursued targets for Parkinson’s disease (PD) therapy. Moreover, it has recently described its role in regulating Wnt signaling and thus, it may be involved in adult neurogenesis. This new hypothesis could give rise to double disease-modifying agents firstly by the benefits of inhibiting LRRK2 and secondly by promoting adult neurogenesis. Herein we report, the design, synthesis, biological evaluation, SAR and potential binding mode of indolinelike LRRK2 inhibitors and their preliminary neurogenic effect in neural precursor cells isolated from adult mice ventricular-subventricular zone. These results open new therapeutic horizons for the use of LRRK2 inhibitors as neuroregenerative agents.Moreover, the indolinone derivatives here prepared, inhibitors of the kinase activity of LRRK2, may be considered as pharmacological probes to study the potential neuroregeneration of the damaged brain.
Descripción46 p.-7 fig.-1 tab.
Versión del editorhttp://dx.doi.org/10.1016/j.ejmech.2017.06.060
URIhttp://hdl.handle.net/10261/152301
DOI10.1016/j.ejmech.2017.06.060
ISSN0223-5234
E-ISSN1768-3254
Aparece en las colecciones: (CIB) Artículos
(IC) Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato
European J. Medicinal Chemistry 2017.pdfPostprint2,4 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

20
checked on 10-mar-2024

WEB OF SCIENCETM
Citations

21
checked on 18-feb-2024

Page view(s)

286
checked on 18-mar-2024

Download(s)

543
checked on 18-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.